ClinConnect ClinConnect Logo

Main Menu

Search for Trials
Browse by Condition
For Industry
Blog
Contact Us
Dark Mode
Log in Sign up

Clinical Trials in Fairhope, Alabama

Find clinical trials in Fairhope, Alabama. Discover local research opportunities and treatment options in your area.

32 Active Trials Found in Fairhope

Showing 32 trials on this page

Page 1 of 2

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

NCT ID: NCT06283966

This clinical trial is studying a new inhaler that combines three medications—budesonide, glycopyrronium, and formoterol—to see how well it works in improving heart and lung health in people with C...

Recruiting
Phase: PHASE3 Conditions: COPD (Chronic Obstructive Pulmonary Disease)

A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

NCT ID: NCT07064473

This clinical trial is studying whether a new medicine called vicadrostat, when taken together with an existing diabetes medicine called empagliflozin, can help lower the risk of heart problems in ...

Recruiting
Phase: PHASE3 Conditions: Hypertension, Diabetes Mellitus, Type 2 +1 more

National Cancer Institute "Cancer Moonshot Biobank"

NCT ID: NCT04314401

The "Cancer Moonshot Biobank" is a clinical trial that aims to gather blood and tissue samples from patients diagnosed with various types of cancer, including advanced stages of breast cancer, lung...

Recruiting
Conditions: Multiple Myeloma, Melanoma +27 more

Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial

NCT ID: NCT04462406

The PET-Stop Trial is a study looking at how doctors can use special tests called biomarkers from PET/CT scans to decide if patients with advanced melanoma can safely stop their anti-PD-1 treatment...

Recruiting
Phase: PHASE2 Conditions: Advanced Melanoma, Unresectable Melanoma +9 more

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

NCT ID: NCT06742723

This clinical trial is studying the effectiveness and safety of a new treatment called Baxdrostat when combined with another medication, Dapagliflozin. The goal is to see how well this combination ...

Recruiting
Phase: PHASE3 Conditions: Chronic Kidney Disease and Hypertension

MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

NCT ID: NCT03072927

This clinical trial is studying a procedure called MILD® (Minimally Invasive Lumbar Decompression) for patients with a condition known as lumbar spinal stenosis, which means there is pressure on th...

Recruiting
Conditions: Lumbar Spinal Stenosis

A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)

NCT ID: NCT06052059

This clinical trial is studying a new medication called tulisokibart (MK-7240) to see if it is effective and safe for people with moderately to severely active ulcerative colitis, a condition that ...

Recruiting
Phase: PHASE3 Conditions: Ulcerative Colitis

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

NCT ID: NCT07037433

This clinical trial is studying a medicine called maridebart cafraglutide to see if it can help people with heart disease who are also overweight or obese. Specifically, the trial wants to find out...

Recruiting
Phase: PHASE3 Conditions: Obesity, Overweight +1 more

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

NCT ID: NCT07037459

This clinical trial is studying a medicine called maridebart cafraglutide to see if it can help people who have heart failure with either preserved or mildly reduced heart function, and who are als...

Recruiting
Phase: PHASE3 Conditions: Obesity, Heart Failure With Preserved Ejection Fraction +1 more

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

NCT ID: NCT06456593

This clinical trial is studying a new medication called obefazimod for people with moderately to severely active Crohn's disease (CD) who have not responded well to other treatments. The trial has ...

Recruiting
Phase: PHASE2 Conditions: Moderately to Severely Active Crohn Disease

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

NCT ID: NCT06677060

This clinical trial is studying the effects of a medication called Baxdrostat combined with Dapagliflozin on heart failure and cardiovascular death in adults aged 40 and older who have type 2 diabe...

Recruiting
Phase: PHASE3 Conditions: Heart Failure

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation

NCT ID: NCT05636176

This clinical trial is studying a new treatment called ziltivekimab for people with heart failure who also have inflammation. Heart failure means the heart isn't pumping blood as well as it should,...

Recruiting
Phase: PHASE3 Conditions: Heart Failure

A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation

NCT ID: NCT06200207

This clinical trial is studying a new medicine called ziltivekimab to see how well it works for people with heart failure and inflammation. Participants in the study will either receive ziltivekima...

Recruiting
Phase: PHASE3 Conditions: Heart Failure, Systemic Inflammation

AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

NCT ID: NCT06793371

The AMBER-HFpEF trial is researching a new medication called CK-4021586 to determine its safety and how well it works for adults suffering from a condition known as heart failure with preserved eje...

Recruiting
Phase: PHASE2 Conditions: Symptomatic Heart Failure With Preserved Ejection Fraction (HFpEF)

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

NCT ID: NCT06511141

This clinical trial, called Sacral Neuromodulation for Male Overactive Bladder (MOAB), is studying a device called the Axonics SNM System to help men who suffer from overactive bladder and urinary ...

Recruiting
Phase: NA Conditions: Prostate Cancer, Overactive Bladder +4 more

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

NCT ID: NCT05918861

This clinical trial is studying a medication called Dalcetrapib to see how it affects heart health in patients who have recently experienced a serious heart event known as Acute Coronary Syndrome (...

Recruiting
Phase: PHASE3 Conditions: Acute Coronary Syndrome

A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.

NCT ID: NCT06268873

This clinical trial is studying a combination of two medications, baxdrostat and dapagliflozin, to see how effective and safe they are for people with chronic kidney disease (CKD) and high blood pr...

Recruiting
Phase: PHASE3 Conditions: Chronic Kidney Disease and Hypertension

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

NCT ID: NCT05174169

This clinical trial, titled "Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease," is looking at how to best choose chemotherapy treatments for patients with Stage III colon cancer ...

Recruiting
Phase: PHASE2 Conditions: Stage III Colon Cancer

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

NCT ID: NCT06307652

This clinical trial is looking at the effects of a combination treatment called balcinrenone and dapagliflozin for patients who have heart failure and kidney problems. The goal is to see how well t...

Recruiting
Phase: PHASE3 Conditions: Heart Failure and Impaired Kidney Function

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

NCT ID: NCT07000357

This clinical trial is studying a medication called AZD0780 to see if it can help reduce serious heart-related events in patients who have a history of cardiovascular disease or are at high risk fo...

Recruiting
Phase: PHASE3 Conditions: Cardiovascular Disease
Search All Trials Browse All Locations